China’s CDH Investments and Sky9 Capital have led a $50 million Series B round for biotech firm RootPath Genomics, while healthcare firm Haoxinqing has secured 200 million yuan ($31 million) in a Series C round led by ByteDance.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
